Medicenna Therapeutics Corp. (TSX:MDNA)
Canada flag Canada · Delayed Price · Currency is CAD
0.8400
0.00 (0.00%)
Aug 1, 2025, 3:59 PM EDT

Vista Outdoor Income Statement

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
Selling, General & Admin
6.015.967.8777.766.53
Upgrade
Research & Development
15.8714.4410.89.314.7210.87
Upgrade
Operating Expenses
21.8820.4118.6716.322.4717.4
Upgrade
Operating Income
-21.88-20.41-18.67-16.3-22.47-17.4
Upgrade
Interest & Investment Income
1.351.351.20.910.070.31
Upgrade
Currency Exchange Gain (Loss)
-0.110.9-0.071.65-0.17-0.21
Upgrade
Other Non Operating Income (Expenses)
7.546.35-7.923.7--
Upgrade
EBT Excluding Unusual Items
-13.1-11.81-25.47-10.05-22.58-17.29
Upgrade
Pretax Income
-13.1-11.81-25.47-10.05-22.58-17.29
Upgrade
Net Income
-13.1-11.81-25.47-10.05-22.58-17.29
Upgrade
Net Income to Common
-13.1-11.81-25.47-10.05-22.58-17.29
Upgrade
Shares Outstanding (Basic)
797770655450
Upgrade
Shares Outstanding (Diluted)
797770655450
Upgrade
Shares Change (YoY)
11.70%10.10%7.57%19.25%9.31%55.68%
Upgrade
EPS (Basic)
-0.17-0.15-0.37-0.16-0.42-0.35
Upgrade
EPS (Diluted)
-0.17-0.15-0.37-0.16-0.42-0.35
Upgrade
Free Cash Flow
-17.71-16.53-16.26-12.66-23.58-15.31
Upgrade
Free Cash Flow Per Share
-0.22-0.22-0.23-0.20-0.43-0.31
Upgrade
EBITDA
-21.84-20.39-18.67-16.3-22.44-17.36
Upgrade
D&A For EBITDA
0.030.02000.040.04
Upgrade
EBIT
-21.88-20.41-18.67-16.3-22.47-17.4
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.